Patrys Limited has released a press release.
Appendix 4E Variance Report
Earlier from Patrys
- First Participants Dosed in RLS-2202 Phase 1A Clinical Trial
- PAB Establishes Clinical Advisory Committee
- Ethics Approval Secured for Phase 1A Clinical Trial
- Investor Presentation - TechKnow Invest Roadshow